Literature DB >> 21460223

Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.

Sebastian Jimenez1, Manuel Torres, Marisa Vizuete, Raquel Sanchez-Varo, Elisabeth Sanchez-Mejias, Laura Trujillo-Estrada, Irene Carmona-Cuenca, Cristina Caballero, Diego Ruano, Antonia Gutierrez, Javier Vitorica.   

Abstract

Neurotrophins, activating the PI3K/Akt signaling pathway, control neuronal survival and plasticity. Alterations in NGF, BDNF, IGF-1, or insulin signaling are implicated in the pathogenesis of Alzheimer disease. We have previously characterized a bigenic PS1×APP transgenic mouse displaying early hippocampal Aβ deposition (3 to 4 months) but late (17 to 18 months) neurodegeneration of pyramidal cells, paralleled to the accumulation of soluble Aβ oligomers. We hypothesized that PI3K/Akt/GSK-3β signaling pathway could be involved in this apparent age-dependent neuroprotective/neurodegenerative status. In fact, our data demonstrated that, as compared with age-matched nontransgenic controls, the Ser-9 phosphorylation of GSK-3β was increased in the 6-month PS1×APP hippocampus, whereas in aged PS1×APP animals (18 months), GSK-3β phosphorylation levels displayed a marked decrease. Using N2a and primary neuronal cell cultures, we demonstrated that soluble amyloid precursor protein-α (sAPPα), the predominant APP-derived fragment in young PS1×APP mice, acting through IGF-1 and/or insulin receptors, activated the PI3K/Akt pathway, phosphorylated the GSK-3β activity, and in consequence, exerted a neuroprotective action. On the contrary, several oligomeric Aβ forms, present in the soluble fractions of aged PS1×APP mice, inhibited the induced phosphorylation of Akt/GSK-3β and decreased the neuronal survival. Furthermore, synthetic Aβ oligomers blocked the effect mediated by different neurotrophins (NGF, BDNF, insulin, and IGF-1) and sAPPα, displaying high selectivity for NGF. In conclusion, the age-dependent appearance of APP-derived soluble factors modulated the PI3K/Akt/GSK-3β signaling pathway through the major neurotrophin receptors. sAPPα stimulated and Aβ oligomers blocked the prosurvival signaling. Our data might provide insights into the selective vulnerability of specific neuronal groups in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460223      PMCID: PMC3099658          DOI: 10.1074/jbc.M110.209718

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

2.  Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.

Authors:  Aileen M Moloney; Rebecca J Griffin; Suzanne Timmons; Rosemary O'Connor; Rivka Ravid; Cora O'Neill
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

3.  Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.

Authors:  Fernanda G De Felice; Diana Wu; Mary P Lambert; Sara J Fernandez; Pauline T Velasco; Pascale N Lacor; Eileen H Bigio; Jasna Jerecic; Paul J Acton; Paul J Shughrue; Elizabeth Chen-Dodson; Gene G Kinney; William L Klein
Journal:  Neurobiol Aging       Date:  2007-04-02       Impact factor: 4.673

4.  Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

Authors:  Pascale N Lacor; Maria C Buniel; Lei Chang; Sara J Fernandez; Yuesong Gong; Kirsten L Viola; Mary P Lambert; Pauline T Velasco; Eileen H Bigio; Caleb E Finch; Grant A Krafft; William L Klein
Journal:  J Neurosci       Date:  2004-11-10       Impact factor: 6.167

5.  Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.

Authors:  Qiu-Lan Ma; Fusheng Yang; Emily R Rosario; Oliver J Ubeda; Walter Beech; Dana J Gant; Ping Ping Chen; Beverly Hudspeth; Cory Chen; Yongle Zhao; Harry V Vinters; Sally A Frautschy; Greg M Cole
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

6.  Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic.

Authors:  Sebastian Jimenez; David Baglietto-Vargas; Cristina Caballero; Ines Moreno-Gonzalez; Manuel Torres; Raquel Sanchez-Varo; Diego Ruano; Marisa Vizuete; Antonia Gutierrez; Javier Vitorica
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

7.  The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo.

Authors:  Juliet K Knowles; Jayakumar Rajadas; Thuy-Vi V Nguyen; Tao Yang; Melburne C LeMieux; Lilith Vander Griend; Chihiro Ishikawa; Stephen M Massa; Tony Wyss-Coray; Frank M Longo
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

8.  Beta-amyloid monomers are neuroprotective.

Authors:  Maria Laura Giuffrida; Filippo Caraci; Bruno Pignataro; Sebastiano Cataldo; Paolo De Bona; Valeria Bruno; Gemma Molinaro; Giuseppe Pappalardo; Angela Messina; Angelo Palmigiano; Domenico Garozzo; Ferdinando Nicoletti; Enrico Rizzarelli; Agata Copani
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

9.  Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}.

Authors:  Wei-Qin Zhao; Pascale N Lacor; Hui Chen; Mary P Lambert; Michael J Quon; Grant A Krafft; William L Klein
Journal:  J Biol Chem       Date:  2009-04-30       Impact factor: 5.157

10.  Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.

Authors:  Dick Terwel; David Muyllaert; Ilse Dewachter; Peter Borghgraef; Sophie Croes; Herman Devijver; Fred Van Leuven
Journal:  Am J Pathol       Date:  2008-02-07       Impact factor: 4.307

View more
  78 in total

Review 1.  Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging.

Authors:  Donat Kögel; Thomas Deller; Christian Behl
Journal:  Exp Brain Res       Date:  2011-11-16       Impact factor: 1.972

Review 2.  Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

Authors:  Mohammed Akbar; Musthafa Mohamed Essa; Ghazi Daradkeh; Mohamed A Abdelmegeed; Youngshim Choi; Lubna Mahmood; Byoung-Joon Song
Journal:  Brain Res       Date:  2016-02-13       Impact factor: 3.252

3.  The Effects of Astilbin on Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Dongmei Wang; Sanqiang Li; Jing Chen; Ling Liu; Xiaoying Zhu
Journal:  Cell Mol Neurobiol       Date:  2016-07-19       Impact factor: 5.046

4.  Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease.

Authors:  C Yi; X Mei; P Ezan; S Mato; I Matias; C Giaume; A Koulakoff
Journal:  Cell Death Differ       Date:  2016-07-08       Impact factor: 15.828

Review 5.  The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.

Authors:  Zi-Xuan Wang; Lan Tan; Jinyuan Liu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

6.  Amyloid precursor protein in pancreatic islets.

Authors:  Joshua A Kulas; Kendra L Puig; Colin K Combs
Journal:  J Endocrinol       Date:  2017-07-14       Impact factor: 4.286

Review 7.  Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences.

Authors:  Philip F Copenhaver; Donat Kögel
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

8.  Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.

Authors:  Xuan Ye; Tuancheng Feng; Prasad Tammineni; Qing Chang; Yu Young Jeong; David J Margolis; Huaibin Cai; Alexander Kusnecov; Qian Cai
Journal:  J Neurosci       Date:  2017-02-03       Impact factor: 6.167

9.  β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.

Authors:  Yulei Deng; Zhe Xiong; Paul Chen; Jing Wei; Shengdi Chen; Zhen Yan
Journal:  Neurobiol Aging       Date:  2013-10-01       Impact factor: 4.673

Review 10.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.